Ttbio Corp. (TPEX:6493)
53.40
-0.40 (-0.74%)
Sep 9, 2025, 1:53 PM CST
Ttbio Revenue
Ttbio had revenue of 179.80M TWD in the half year ending December 31, 2024, a decrease of -21.60%. This brings the company's revenue in the last twelve months to 392.72M, up 38.21% year-over-year. In the year 2024, Ttbio had annual revenue of 312.12M, down -1.88%.
Revenue (ttm)
392.72M
Revenue Growth
+38.21%
P/S Ratio
4.12
Revenue / Employee
3.33M
Employees
118
Market Cap
1.62B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 312.12M | -5.97M | -1.88% |
Dec 31, 2023 | 318.09M | -100.79M | -24.06% |
Dec 31, 2022 | 418.88M | 113.37M | 37.11% |
Dec 31, 2021 | 305.52M | 126.56M | 70.72% |
Dec 31, 2020 | 178.96M | -87.62M | -32.87% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 12.63B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lotus Pharmaceutical | 19.12B |
Lumosa Therapeutics | 37.25M |
Oneness Biotech | 112.57M |
Polaris Group | 64.02M |
Center Laboratories | 1.60B |